The Scientist - Home

With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

Scientists hoping to treat immunodeficiencies using gene therapy have found a way to edit stem cells in mice without disrupting gene regulation.

Mammalian cells outpace bacteriophages in the microbial food chain by devouring phages to fuel their growth.

Neurons linked to metabolic processes slow aging in mice.

E. coli divides faster than it can replicate its genome, while simultaneously expressing its genes. Scientists recently revealed the intricate molecular coordination that makes this possible.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.

Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe.

Basic research successes offer glimpses into future scientific advancements, but the outcomes are subject to change.

Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.

Engineered natural killer cells track down cancer cells in the bone marrow.